Member Exclusive

Epithelial Na+ channel inhibitors for the treatment of cystic fibrosis

In this patent review, brought to MedChemNet users by our sister journal Pharmaceutical Patent Analyst, the authors summarize their patent applications in regards to cystic fibrosis treatment via the inhibition of epithelial Na+ channels.

Go to the profile of MedChemNet
Aug 03, 2017

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.